Growth Metrics

Vertex Pharmaceuticals (VRTX) Property, Plant & Equipment (Net) Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -14.40%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -9.89%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -0.31%
10 Revolution Medicines 31.20 Bn 31.20 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.10%
Dec 31, 2025 11.11%
Sep 30, 2025 8.40%
Jun 30, 2025 6.67%
Mar 31, 2025 5.38%
Dec 31, 2024 3.92%
Sep 30, 2024 2.36%
Jun 30, 2024 5.55%
Mar 31, 2024 5.95%
Dec 31, 2023 6.55%
Sep 30, 2023 6.87%
Jun 30, 2023 15.51%
Mar 31, 2023 14.72%
Dec 31, 2022 14.16%
Sep 30, 2022 15.11%
Jun 30, 2022 14.59%
Mar 31, 2022 14.25%
Dec 31, 2021 10.45%
Sep 30, 2021 8.84%
Jun 30, 2021 7.77%
Mar 31, 2021 7.19%
Dec 31, 2020 6.68%
Sep 30, 2020 6.61%
Jun 30, 2020 -0.53%
Mar 31, 2020 1.30%
Dec 31, 2019 2.18%
Sep 30, 2019 2.18%
Jun 30, 2019 1.92%
Mar 31, 2019 2.45%
Dec 31, 2018 5.19%
Sep 30, 2018 4.58%
Jun 30, 2018 4.58%
Mar 31, 2018 4.16%
Dec 31, 2017 3.32%
Sep 30, 2017 1.78%
Jun 30, 2017 0.46%
Mar 31, 2017 -0.82%
Dec 31, 2016 0.07%
Sep 30, 2016 1.95%
Jun 30, 2016 5.89%
Mar 31, 2016 11.05%
Dec 31, 2015 17.18%
Sep 30, 2015 78.55%
Jun 30, 2015 37.81%
Mar 31, 2015 60.83%
Dec 31, 2014 75.17%
Sep 30, 2014 92.37%
Mar 31, 2014 117.20%
Dec 31, 2013 112.79%
Sep 30, 2013 114.84%
Jun 30, 2013 112.72%
Mar 31, 2013 105.49%
Dec 31, 2012 90.95%